Currently, we are performing a phase 2 open-label study that examines the effect of co-administration of C1-INH and blood transfusion in severe cAIHA on the recovery of allogeneic RBCs (ClinicalTrialsRegister.eu: 2012-003710-13). The gene discussed is SERPING1; the disease is autoimmune hemolytic anemia, cold type.